






The aging brain is perhaps the most fragile of tissues, 
with a population of structurally elaborate and 
metabolically demanding neurons that are seldom 
replenished during adulthood. Neurodegenerative 
disorders such as Alzheimer's disease (AD) and acute 
insults such as an ischemic stroke lead to seemingly 
irreparable damage that impairs cognitive and/or motor 
function.  Considerable evidence suggests that the 
vulnerability of neurons to aging and associated 
disorders can be modified by environmental factors 
including dietary energy intake and exercise [1,2,3].     
Energy (caloric) restriction (CR) and exercise induce 
the expression of neurotrophic factors, including brain-
derived neurotrophic factor (BDNF), cytoprotective 
protein chaperones, and proteins that can prevent 
apoptosis.    The mechanisms responsible for the neuro-
protective effects of CR and exercise are mediated, in 
part, by changes in gene transcription [3].  However, 
new findings reported in this issue of Aging suggest a 
role for down-regulation of microRNAs (miRNAs) that 
target mRNAs encoding cell survival proteins in the 
beneficial effects of CR on the aging brain [4].    
 
miRNAs are short non-coding RNAs that typically bind 
to scores of transcripts an inhibit translation of the 
targeted mRNA [5].  Khanna et al found that levels of 
three miRNAs (miR-34a, miR30e and miR181-a-1*) 
are significantly lower in brain tissue samples from old 
mice (24-28 months-old) that had been maintained on a 
CR diet (40% CR beginning at 4 months of age) 
compared to mice on the usual ad libitum diet.     
Interestingly, all three of these miRNAs were predicted 
to have at least one target site for Bcl2, an anti-
apoptotic protein previously been shown to increase 
with CR. The authors confirmed the repressive action of  
 
 

















these miRNAs on Bcl2. These changes in miRNA 
expression were validated in both cortical and 
hippocampal tissues, suggesting a more global 
repression of these miRNAs in the CNS due to CR. 
 
Although the authors chose to solely investigate Bcl2 as 
a target of these three miRNAs in mediating the 
beneficial effects of CR, eight additional shared mRNA 
targets were found using multiple target-prediction 
algorithms. One of these targets, cAMP response 
element binding protein 1 (CREB1), is an important 
activator of several immediate response genes that are 
critical to synaptic plasticity [6]. Repression of CREB1 
by these three age-dependent miRNAs could play a role 
in the cognitive decline observed with aging. 
Additionally, huntingtin (Htt) is a predicted target of 
these miRNAs, and this possible interaction may play a 
role in the beneficial effects of dietary energy restriction 
in Htt mutant mice, a model of Huntington’s disease 
[7]. Moreover, previous research demonstrated that 
miR-30a, which has an identical seed region to miR-30e 
acts to functionally repress BDNF expression in the 
cortex [8]. Up-regulation of BDNF by CR has been 
shown to mediate, in part, the increased neurogenesis by 
CR and is also thought to play an important role in 
learning and memory [9,10]. Although not explored by 
Khanna and colleagues in the context of CR, the 
regulation of BDNF by the miR-34 family represents 
yet another potential avenue for miRNAs as mediators 
of effects of dietary energy intake on neuronal 
vulnerability in aging and disease. 
 
It will be important to determine whether changes in the 
expression of miRNAs 34a, 30e, and 181a do in fact 
mediate effects of energy intake on neuronal vulnerabil- 
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knocking down each of these miRNAs in neurons of 
interest in animal models of Alzheimer’s, Parkinson’s 
and Huntington’s diseases.  Whether Bcl-2 is a pivotal 
target of this miRNAs could be determined in 
experiments with Bcl-2 deficient mice.   It seems likely 
that the findings of Khanna et al. [4] represent the ‘tip 
of the iceberg’ with regards to miRNAs in brain aging 
and disease as there are undoubtedly numerous other 
miRNAs and target mRNAs involved in regulating 
neuronal survival and plasticity.  This arena of research 
is a promising area for the development of novel 
therapeutic interventions in neurodegenerative disor-
ders.  Indeed, multiple miRNAs appear to be dysreg-
ulated in neurological diseases [5]. Initial studies in 
non-human primates have further emphasized the 
potential for miRNA-based theraputics [11]. The work 
by Khanna and colleagues suggest a potential for 
miRNA-based therapies that utilize the same anti-
apoptic mechanisms as CR. However, as a single 
miRNA can regulate hundreds of transcripts, systemic 
delivery of a miRNA mimetic or sponge may result in 
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